Shopping Cart 0
Cart Subtotal
USD 0

Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Eagle Pharmaceuticals Inc (EGRX) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

Eagle Pharmaceuticals Inc (Eagle Pharma) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company's commercial product portfolio encompasses pharmaceutical injectables, including Ryanodex for exertional heatstroke; Argatroban for thrombosis; diclofenac sodium misoprostol forosteoarthritis for rheumatoid arthritis; and docetaxel injection for oncology. Eagle pharma's pipeline spans investigational candidates including Bendamustine RTD for chronic lymphocytic leukemia and non Hodgkin's lymphoma; Bivalirudin for percutaneous transluminal angioplasty; and Pemetrexed for locally advanced or metastatic non small cell lung cancer and mesothelioma. The company's products cater to patients and healthcare professionals in the areas of critical care, orphan diseases, and oncology. Eagle Pharmaceuticals is headquartered in New Jersey, the US.

Eagle Pharmaceuticals Inc Key Recent Developments

May 10,2018: Eagle Pharmaceuticals Reports First Quarter 2018 Results

Mar 27,2018: Eagle Pharmaceuticals Announces New Patent for Eagle Biologics

Feb 26,2018: Eagle Pharmaceuticals Reports Fourth Quarter 2017 Financial Results

Nov 08,2017: Eagle Pharmaceuticals Reports Third Quarter 2017 Results

Aug 09,2017: Eagle Pharmaceuticals Reports Second Quarter 2017 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 About the Company 6

Eagle Pharmaceuticals Inc Key Facts 6

Eagle Pharmaceuticals Inc Key Employees 7

Eagle Pharmaceuticals Inc Key Employee Biographies 8

Eagle Pharmaceuticals Inc Major Products and Services 10

Eagle Pharmaceuticals Inc History 11

Eagle Pharmaceuticals Inc Company Statement 12

Eagle Pharmaceuticals Inc Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2 Company Analysis 17

Company Overview 17

Eagle Pharmaceuticals Inc Business Description 18

R&D Overview 18

Eagle Pharmaceuticals Inc Corporate Strategy 19

Eagle Pharmaceuticals Inc SWOT Analysis 20

SWOT Analysis Overview 20

Eagle Pharmaceuticals Inc Strengths 20

Eagle Pharmaceuticals Inc Weaknesses 21

Eagle Pharmaceuticals Inc Opportunities 22

Eagle Pharmaceuticals Inc Threats 23

Eagle Pharmaceuticals Inc Key Competitors 24

Section 3 Company Financial Ratios 25

Financial Ratios Capital Market Ratios 25

Financial Ratios Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios Interim Ratios 30

Financial Ratios Ratio Charts 31

Section 4 Company's Lifesciences Financial Deals and Alliances 32

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Eagle Pharmaceuticals Inc, Recent Deals Summary 34

Section 5 Company's Recent Developments 35

May 10, 2018: Eagle Pharmaceuticals Reports First Quarter 2018 Results 35

Mar 27, 2018: Eagle Pharmaceuticals Announces New Patent for Eagle Biologics 37

Nov 08, 2017: Eagle Pharmaceuticals Reports Third Quarter 2017 Results 38

Aug 09, 2017: Eagle Pharmaceuticals Reports Second Quarter 2017 Results 40

May 15, 2017: Eagle Pharmaceuticals Appoints Pete A. Meyers as Chief Financial Officer 42

May 08, 2017: Eagle Pharmaceuticals Reports First Quarter 2017 Results 43

Mar 16, 2017: Eagle Pharmaceuticals Appoints Richard A. Edlin to Board of Directors 44

Mar 16, 2017: Eagle Pharmaceuticals Appoints Richard A. Edlin to Board of Directors 45

Mar 01, 2017: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 46

Section 6 Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Eagle Pharmaceuticals Inc, Performance Chart (2013 2017) 29

Eagle Pharmaceuticals Inc, Ratio Charts 31

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33


List Of Table

List of Tables

Eagle Pharmaceuticals Inc, Key Facts 6

Eagle Pharmaceuticals Inc, Key Employees 7

Eagle Pharmaceuticals Inc, Key Employee Biographies 8

Eagle Pharmaceuticals Inc, Major Products and Services 10

Eagle Pharmaceuticals Inc, History 11

Eagle Pharmaceuticals Inc, Subsidiaries 16

Eagle Pharmaceuticals Inc, Key Competitors 24

Eagle Pharmaceuticals Inc, Ratios based on current share price 25

Eagle Pharmaceuticals Inc, Annual Ratios 26

Eagle Pharmaceuticals Inc, Annual Ratios (Cont...1) 27

Eagle Pharmaceuticals Inc, Annual Ratios (Cont...2) 28

Eagle Pharmaceuticals Inc, Interim Ratios 30

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Eagle Pharmaceuticals Inc, Recent Deals Summary 34

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Eagle Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Lexicon Pharmaceuticals Inc

Karyopharm Therapeutics Inc

Cardinal Health Inc

Agios Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc

Acadia Pharmaceuticals Inc